NO20084993L - Forklaring, metoder, og prover for identifisering av nye smakscelle-gener og saltsmak-reseptor mal og prover som anvender disse identifiserte genene eller gen-produktene - Google Patents

Forklaring, metoder, og prover for identifisering av nye smakscelle-gener og saltsmak-reseptor mal og prover som anvender disse identifiserte genene eller gen-produktene

Info

Publication number
NO20084993L
NO20084993L NO20084993A NO20084993A NO20084993L NO 20084993 L NO20084993 L NO 20084993L NO 20084993 A NO20084993 A NO 20084993A NO 20084993 A NO20084993 A NO 20084993A NO 20084993 L NO20084993 L NO 20084993L
Authority
NO
Norway
Prior art keywords
taste
genes
methods
umami
bitter
Prior art date
Application number
NO20084993A
Other languages
English (en)
Norwegian (no)
Inventor
Bryan Moyer
Min Lu
Fernando Echeverri
Dalia Kalabat
Na Gao
Peter Hevezi
Original Assignee
Senomyx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senomyx Inc filed Critical Senomyx Inc
Publication of NO20084993L publication Critical patent/NO20084993L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1072—Differential gene expression library synthesis, e.g. subtracted libraries, differential screening
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1086—Preparation or screening of expression libraries, e.g. reporter assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20084993A 2006-06-08 2008-11-28 Forklaring, metoder, og prover for identifisering av nye smakscelle-gener og saltsmak-reseptor mal og prover som anvender disse identifiserte genene eller gen-produktene NO20084993L (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US81176306P 2006-06-08 2006-06-08
US83119906P 2006-07-17 2006-07-17
US84899506P 2006-10-04 2006-10-04
US86617806P 2006-11-16 2006-11-16
PCT/US2007/013502 WO2007146120A2 (fr) 2006-06-08 2007-06-08 Logique, procédés et essais servant à identifier de nouveaux gènes de cellules gustatives et de nouvelles cibles des récepteurs du goût salé et essais utilisant ces gènes identifiés ou des produits génétiques dérivés de ceux-ci

Publications (1)

Publication Number Publication Date
NO20084993L true NO20084993L (no) 2008-11-28

Family

ID=38832404

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084993A NO20084993L (no) 2006-06-08 2008-11-28 Forklaring, metoder, og prover for identifisering av nye smakscelle-gener og saltsmak-reseptor mal og prover som anvender disse identifiserte genene eller gen-produktene

Country Status (10)

Country Link
US (1) US20080261824A1 (fr)
EP (1) EP2024518A4 (fr)
JP (1) JP2009539377A (fr)
AU (1) AU2007258511A1 (fr)
CA (1) CA2654552A1 (fr)
IL (1) IL195205A0 (fr)
MX (1) MX2008015314A (fr)
NO (1) NO20084993L (fr)
TW (1) TW200813232A (fr)
WO (1) WO2007146120A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10078087B2 (en) 2001-05-01 2018-09-18 Senomyx, Inc. Assays and enhancers of the human delta ENaC sodium channel
JP2007528712A (ja) 2003-07-10 2007-10-18 セノミックス、インコーポレイテッド ヒトＥＮａＣを発現する卵母細胞を用いた改良された電気生理学的アッセイ及び膜電位リポーター色素を用いたアッセイにおけるＥＮａＣ相乗剤の効果を向上させるためのフェナミルの使用
EP2557087A1 (fr) * 2006-10-19 2013-02-13 Monell Chemical Senses Center Récepteur humain du goût salé et procédés de modulation de la perception du goût salé
EP2164976A4 (fr) * 2007-06-08 2010-06-30 Senomyx Inc Nouvelle logique, méthodes et essais visant à identifier des gène spécifiques du goût chez des primates humains et non humains, utilisation dans un modulateur du goût et essais de criblage thérapeutiques
US20090210953A1 (en) * 2007-06-08 2009-08-20 Bryan Moyer Identification of TRPML3 (MCOLN3) as a salty taste receptor and use in assays for identifying taste (salty) modulators and/or therapeutics that modulate sodium transport, absorption or excretion and/or aldosterone, and/or vasopressin production or release
WO2010065863A2 (fr) * 2008-12-05 2010-06-10 Senomyx, Inc. Dosages pour identifier des gènes codants pour des récepteurs et des modulateurs du goût salé
US20100319075A1 (en) * 2009-06-12 2010-12-16 Monell Chemical Senses Center STG Promoter And Its Use As A Marker For Taste And Oocyte Cells
CN102575279B (zh) * 2009-09-29 2018-03-20 味之素株式会社 咸味调节物质的筛选方法
JP5627479B2 (ja) * 2011-01-24 2014-11-19 日清食品ホールディングス株式会社 Ｓｋｎ−１ａ／ｉノックアウトマウスを用いた味蕾細胞マーカー分子の探索方法
CN114366802A (zh) * 2015-04-22 2022-04-19 西达-赛奈医疗中心 用于治疗2型糖尿病的肠内递送的苦味寡肽
JP7357282B2 (ja) * 2017-12-28 2023-10-06 日清食品ホールディングス株式会社 塩味受容体を用いた塩味増強剤のスクリーニング方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750339A (en) * 1994-11-30 1998-05-12 Thomas Jefferson University Methods for identifying fetal cells
US7041448B2 (en) * 2000-08-18 2006-05-09 The ML4 Foundation Gene encoding a new TRP channel is mutated in mucolipidosis IV
US20020164645A1 (en) * 2000-12-29 2002-11-07 The Regents Of The University Of California Assays for taste receptor cell specific ion channel
TW201022287A (en) * 2001-01-03 2010-06-16 Senomyx Inc T1R taste receptors and genes encoding same
US7368285B2 (en) * 2001-03-07 2008-05-06 Senomyx, Inc. Heteromeric umami T1R1/T1R3 taste receptors and isolated cells that express same
IL158488A0 (en) * 2001-04-20 2004-05-12 Sinai School Medicine Tir3 a novel taste receptor
CA2452716C (fr) * 2001-07-03 2012-06-26 The Regents Of The University Of California Recepteurs de gout heterodimeriques de gout sucre et d'acide amine, chez les mammiferes
DE10155130A1 (de) * 2001-11-12 2003-05-22 Max Delbrueck Centrum Verfahren zur Isolierung von Neuronen
US20050266442A1 (en) * 2004-03-25 2005-12-01 Rachel Squillace Immortalized human Tuberous Sclerosis null angiomyolipoma cell and method of use thereof

Also Published As

Publication number Publication date
AU2007258511A1 (en) 2007-12-21
EP2024518A4 (fr) 2010-05-26
TW200813232A (en) 2008-03-16
MX2008015314A (es) 2008-12-12
WO2007146120A2 (fr) 2007-12-21
EP2024518A2 (fr) 2009-02-18
JP2009539377A (ja) 2009-11-19
IL195205A0 (en) 2009-08-03
WO2007146120A3 (fr) 2008-12-04
CA2654552A1 (fr) 2007-12-21
US20080261824A1 (en) 2008-10-23

Similar Documents

Publication Publication Date Title
NO20084993L (no) Forklaring, metoder, og prover for identifisering av nye smakscelle-gener og saltsmak-reseptor mal og prover som anvender disse identifiserte genene eller gen-produktene
Zhu et al. Transplantation of microbiota from drug-free patients with schizophrenia causes schizophrenia-like abnormal behaviors and dysregulated kynurenine metabolism in mice
Agalliu et al. Associations of oral α-, β-, and γ-human papillomavirus types with risk of incident head and neck cancer
Liu et al. Epidemiology of acute respiratory infections in children in Guangzhou: a three-year study
Ohba et al. GRIN 1 mutations cause encephalopathy with infantile‐onset epilepsy, and hyperkinetic and stereotyped movement disorders
Xu et al. Chronic alcohol exposure induced gut microbiota dysbiosis and its correlations with neuropsychic behaviors and brain BDNF/Gabra1 changes in mice
Shimmura et al. Alteration of plasma glutamate and glutamine levels in children with high-functioning autism
ECSP099833A (es) Anticuerpos humanizados contra el globulomero a?(20-42) y sus usos
NO20081838L (no) 5-lipoksygenaseaktiverende protein-(FLAP)-inhibitorer
EA200900959A1 (ru) Ингибиторы мек
BR112015017686A2 (pt) métodos e sistemas para usar um ambiente de computação em nuvem para compartilhar dados biológicos relacionados
EP1855719A4 (fr) Neutralisation d'anticorps monoclonaux contre le coronavirus associe au syndrome respiratoire aigu severe
BRPI0507856A (pt) composição farmacêutica, e, processo para preparar o anticorpo abeta
MX2010003884A (es) Anticuerpo dirigido a la proteina lecitina similar a inmunoglobulina de union a acido sialico-15 relacionado con osteoclastos.
MY153198A (en) Inhibitors of protein aggregation
BRPI0812770A2 (pt) Método in vitro para identificar uma pluralidade de moléculas antigênicas transportadas por eritrócitos de um indivíduo, e/ou identificar uma pluralidade de anticorpos contra moléculas antigênicas transportadas por eritrócitos, conjunto de reagentes para implementar o método de detecção .
TR201900975T4 (tr) Yetişkin multipotansiyel mezenkimal prekürsör hücrelerin tanımlaması ve/veya zenginleştirmesi için markör olarak ısı şok proteini 90-beta'nın kullanımı.
EA200970112A1 (ru) Документ, снабженный идентифицирующими и верификационными данными
NO20081847L (no) Fremgangsmate for a forbedre kognitiv funksjon
EA202090097A1 (ru) Способ оценки эффектов композиции, содержащей микроорганизмы, на кишечную микробиоту
Martínez et al. Gastrin-releasing peptide (GRP) induces angiogenesis and the specific GRP blocker 77427 inhibits tumor growth in vitro and in vivo
WO2011044437A3 (fr) Procédés de séquençage de polonies (pour « polymerase colonies »)
Villar et al. Coronavirus in cat flea: findings and questions regarding COVID-19
Fredricks The human microbiota: how microbial communities affect health and disease
TR201820975A2 (tr) İbuprofen, Psödoefedrin ve Erdostein İçeren Uzatılmış Salım Sağlayan Farmasötik Kompozisyon

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application